Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4784-4789

  Cinco, M ^a   Murgia, R ^a   Presani, G ^b   Perticarari, S ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; FIBRINOGEN; INTEGRIN; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINE;

ANIMAL CELL; ARTICLE; BACTERIUM ADHERENCE; BORRELIA BURGDORFERI; CHO CELL; HUMAN; HUMAN CELL; NONHUMAN; OPSONIZATION; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0030809878     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4784-4789.1997     Document Type: Article

References (29)

1. Asbrink, E., and A. Hovmark. 1985. Successful cultivation of spirochetes from skin lesions of patients with Erythema chronicum migrans Afzelius and Acrodermatitis chronica atrophicans. Acta Pathol. Microbiol. Immunol. Scand. 93:161-163.
2. Backenson, P. B., J. L. Coleman, and J. L. Benach. 1995. Borrelia burgdorferi shows specificity of binding to glycosphingolipids. Infect. Immun. 63:2811-2817.
3. Banfi, E., M. Cinco, S. Perticarari, and G. Presani. 1989. Rapid flow cytometric studies of Borrelia burgdorferi phagocytosis by human polymorphonuclear leucocytes. J. Appl. Bacteriol. 67:37-45.
4. Benach, J. L., H. B. Fleit, G. S. Habicht, J. L. Coleman, E. M. Bosler, and B. P. Lane. 1984. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J. Infect. Dis. 150:497-507.
5. Cinco, M., R. Murgia, G. Presani, and S. Perticarari. 1994 Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol. Lett. 122:187-194.
6. 3 mediates binding of the Lyme disease agent Borrelia burgdoferi to human platelets. Proc. Natl. Acad. Sci. USA 90:7059-7063.
7. Diamond, M. S., J. Garcia Aguilar, J. K. Bickford, A. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leucocyte integrin Mac-1 (CD11b/CD18) of four distinct adhesion ligands. J. Cell Biol. 120:1031-1043.
8. Diamond, M. S., and T. A. Springer. 1993. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120:545-556.
9. Drevets, D. A., and P. A. Campbell. 1991. Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun. 59:2645-2652.
10. Hondalus, M. K., M. S. Diamond, L. A. Rosenthal, T. A. Springer, and D. Mosser. 1993. The intracellular bacterium Rhodncoccus equi requires Mac-1 to bind to mammalian cells. Infect. Immun. 61:2919-2929.
11. Hulinska, D., P. Volf, and L. Grubhoffer. 1992. Characterization of Borrelia burgdorferi glycoconjugates and surface carbohydrates. Zentralbl. Bakteriol. 276:473-480.
12. Isaacs, R. 1994. Borrelia hurgdorferi binding to epithelial cell proteoglycan. J. Clin. Invest. 93:809-819.
13. Kochi, S. K., and R. C. Johnson. 1988. Role of immunoglobulin G in killing of Borrelia burgdorgfen by the classical complement pathway. Infect. Immun. 56:314-321.
14. Leong, J., P. E. Morissey, E. Ortega-Barria, M. E. A. Pereira, and J. Coburn. 1995. Hemagglutination and proteoglycan binding by the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63:874-883.
15. Montgomery, K. R., M. H. Nathanson, and S. E. Malawista. 1993. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. J. Immunol. 150:909-915.
16. Montgomery, R. R., M. H. Nathanson, and S. E. Malawista. 1994. Fc and non-FC mediated phagocytosis of Borrelia burgdorferi by macrophages. J. Infect. Dis. 170:890-893.
17. Montgomery, R. R., and S. E. Malawista. 1996. Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect. Immun. 64:2867-2872.
18. Mosser, D. M., and P. J. Edelson. 1985. The mouse macrophage receptor for iC3b (CR3) is a major mechanism in the phagocytosis of Leshmania promastigotes. J. Immunol. 135:2785-2789.
19. Payne, N. R., and M. A. Horwitz. 1987. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J. Exp. Med. 166:1377-1389.
20. Peterson, P. K., C. C. Clawson, D. A. Lee, D. J. Garlich, P. G. Quie, and R. C. Johnson. 1984. Human phagocyte interactions with the Lyme disease spirochete chete. Infect. Immun. 46:608-611.
21. Relman, D., E. Tuomanen, S. Falkow, D. T. Golenbock, K. Saukkonen, and S. Wright. 1990. Recognition of a bacterial adhesin by an integrin: macro- phage CR3 (αmβ2. CD11b,/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382.
22. Rittig, M. G., J. C. Jagoda, B. Wilske, R. Murgia, R. Repp, G. R. Burmester, and A. Krause. Coiling phagocytosis discriminates morphologically similar spirochetes and is enhanced by phorbol myristate and GM-CSF. Submitted for publication.
23. Ross, G. D., J. A. Cain, B. L. Myones, S. L. Newman, and P. J. Lachmann. 1987. Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement 4:61-74.
24. Sambri, V., C. Stefanelli, and R. Cevenini. 1992. Detection of glycoproteins in Borrelia burgdorferi. Arch. Microbiol. 157:205-208.
25. Schnur, R. A., and S. L. Newman. 1990. The respiratory burst response to Histoplasma capsulatum by human neutrophils. J. Immunol. 12:4765-4772.
26. Sutterwala, F. S., L. A. Rosenthal, and D. Mosser. 1996. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement- opsonizcd particles. J. Leukocyte Biol. 59:883-890.
27. Thornton, B. P., V. Vetvicka, M. Pitman, R. C. Goldman, and G. D. Ross. 1996. Analysis of the sugar specificity and molecular location of the β-glucan binding lectin site of complement receptor type3 (CD11b/CD18). J Immunol. 156:1235-1246.
28. Vetvicka, V., B. P. Thornton, and G. Ross. 1996. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98:50-61.
29. Wright, S. D., S. M. Levin, M. T. C. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CH11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169:175-183.